Companies /Healthcare

Merck & Co Inc

NYSE: MRK Drug Manufacturers - General
$149.50
▲ $2.63 (+1.79%) today
Markets closed · 9:56pm ET

MRK Coverage

Page 68
3:42pm ET
Health and Healthcare

The Great Merck Buyback.. Dividend Too (MRK)

Merck & Co., Inc. (NYSE: MRK) barely has its Schering-Plough deal behind it.  And today came the announcement of its dividend rate, but more importantly came word of a large share repurchase…

MRK
Douglas A. McIntyre
4:11pm ET
Health and Healthcare

52-Week High Club (DDS, DBRN, SJM, MRK)

Dillard’s Inc. (NYSE: DDS) rose as high as over 10% to a yearly high of $15.79 after the department-store chain was upgraded by Deutsche Bank AG.   Dress Barn Inc. (NASDAQ: DBRN)…

Douglas A. McIntyre
4:02pm ET
Technology

52-Week High Club (FDX, LNY, MRK, GOOG)

FedEx Corp. (NYSE: FDX) over 3% to a yearly high of $84.92.  Barron’s reported that the package delivery company may rise as high as $100 dollars according to a survey of investors…

Douglas A. McIntyre
2:54am ET
Media

Media Digest 7/24/2009 Reuters, WSJ, NYTimes, FT. Bloomberg

Reuters: Microsoft’s (MSFT) results and forecast were weak. Reuters:   CIT (CIT) may sell its aviation finance business. Reuters:   Fatigue at the Fed is leading to questions about its expanded role. Reuters:   Twitter…

Douglas A. McIntyre
4:01am ET
Health and Healthcare

The Next Blockbuster Drugs: A $170 Billion Opportunity

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market. With help…

Douglas A. McIntyre